A recent comparative RNA-seq analysis identified that many genes are commonly upregulated in both gliomas (eg., IDH wild-type) and BrMs, including the angiogenic factor VEGFA, growth factors PDGFA, TGFB1, SPP1, and the protease inhibitor TIMP-116. Here, VEGFA is linked to central nervous system cancer.